CDT Equity CDT
NASDAQ CDT
$0.99 -0.26 (-20.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

CDT Equity (CDT) Return on Equity [ROE] (2025 - 2026)

Updated

CDT Equity's Return on Equity [ROE] was -33.49% in Q2 2026, up 516.88 percentage points from -550.37% a year earlier and up 41.53 percentage points from the prior quarter.

Analysis

CDT Equity (CDT) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

From Q2 2025 onward, CDT Equity has reported Return on Equity [ROE] for 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.32%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 84.40%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 21.39%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 83.75%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -18.38%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 4.97%
10 CDT Equity 31,553.75 31,553.75 - -33.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.49%
Mar 31, 2026 -75.02%
Sep 30, 2025 -489.13%
Jun 30, 2025 -550.37%
API Access

CDT Equity Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CDT&period=max&api_key=YOUR_API_KEY